Avanos Medical (NYSE:AVNS – Get Free Report) issued an update on its FY 2024 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 1.300-1.350 for the period, compared to the consensus earnings per share estimate of 1.390. The company issued revenue guidance of $683.0 million-$688.0 million, compared to the consensus revenue estimate of $695.2 million.
Avanos Medical Price Performance
AVNS stock traded up $0.03 during trading on Friday, hitting $18.71. The company had a trading volume of 441,974 shares, compared to its average volume of 237,900. The company has a fifty day moving average price of $23.23 and a two-hundred day moving average price of $21.48. The company has a current ratio of 2.22, a quick ratio of 1.49 and a debt-to-equity ratio of 0.12. Avanos Medical has a fifty-two week low of $17.39 and a fifty-two week high of $25.36. The company has a market cap of $859.72 million, a P/E ratio of 54.94 and a beta of 0.91.
Avanos Medical (NYSE:AVNS – Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.36 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.36. Avanos Medical had a return on equity of 4.70% and a net margin of 2.30%. The firm had revenue of $170.40 million during the quarter, compared to the consensus estimate of $175.03 million. Equities research analysts expect that Avanos Medical will post 1.33 earnings per share for the current fiscal year.
Analysts Set New Price Targets
View Our Latest Report on AVNS
Avanos Medical Company Profile
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Further Reading
- Five stocks we like better than Avanos Medical
- 3 Healthcare Dividend Stocks to Buy
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- CD Calculator: Certificate of Deposit Calculator
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- Stock Dividend Cuts Happen Are You Ready?
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.